Document Detail


Efficient In Vitro Labeling of Human Prostate Cancer Cells with Superparamagnetic Iron Oxide Nanoparticles.
MedLine Citation:
PMID:  21812654     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Abstract The purpose of this study was to investigate the feasibility and optimization of protocols using superparamagnetic iron oxide (SPIO) nanoparticles to label human prostate cancer cell lines PC3 in vitro. The PC3 cells were labeled with different concentrations (28-252 μg Fe/mL) of SPIO and increasing incubation time (6-24 hours), in the presence or absence of a transfection agent poly-l-lysine (PLL). The cell labeling efficiency was analyzed by Prussian blue stain method. The cellular viability was evaluated using trypan blue dye exclusion test. The signal intensity change of the labeled cells was assessed with magnetic resonance imaging (MRI). The results demonstrated that the iron oxide uptake by PC3 cells was dependent on dose and time. The PLL significantly increased the iron load of cells (p<0.01). A final concentration of SPIO nanoparticles of 42-126 μg/mL with 12-24 hours incubation times could be sufficient to label PC3 cells for cellular MRI without impairment of cell viability. This technology may allow for further study into the mechanisms underlying prostate cancer progression as well as permit the real-time imaging of the effectiveness of cancer therapies in vivo.
Authors:
Jun Jiang; Yaqing Chen; Yunkai Zhu; Xiaohong Yao; Jun Qi
Related Documents :
9250404 - Major stress protein hsp70 interacts with nf-kb regulatory complex in human t-lymphoma ...
3180064 - Nuclear fragmentation and premature chromosome condensation induced by heat shock in s-...
8660264 - The ability of heat stress and metabolic preconditioning to protect primary rat cardiac...
7721954 - Integrity of intermediate filaments is associated with the development of acquired ther...
6147124 - Somatostatin and/or somatostatin-like immunoreactive endocrine-paracrine cells in the h...
6119694 - Monoclonal anti-tyrosine hydroxylase antibodies.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-8-3
Journal Detail:
Title:  Cancer biotherapy & radiopharmaceuticals     Volume:  -     ISSN:  1557-8852     ISO Abbreviation:  -     Publication Date:  2011 Aug 
Date Detail:
Created Date:  2011-8-4     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9605408     Medline TA:  Cancer Biother Radiopharm     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
1 Department of Ultrasound, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine , Shanghai, China .
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Features Associated with Survival in Metastatic Melanoma Patients Treated with Patient-Specific Dend...
Next Document:  The Changing Face of Staphylococcus aureus: A Continuing Surgical Challenge.